about
The promise of neuroprotective agents in Parkinson's diseaseGlutamate receptors in neuroinflammatory demyelinating diseaseRole of Peroxisome Proliferator-Activated Receptors in Inflammation ControlNonsteroidal anti-inflammatory drugs and risk of Parkinson's diseaseFunction of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the ductus arteriosus from foetal lamb: differential development and change by oxygen and endotoxinAltered mRNA editing and expression of ionotropic glutamate receptors after kainic acid exposure in cyclooxygenase-2 deficient mice.The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus.Nonlinear neurovascular coupling in rat sensory cortex by activation of transcallosal fibers.Microsomal prostaglandin E synthase-1 and cyclooxygenase-2 are both required for ischaemic excitotoxicityEmerging roles of PGE2 receptors in models of neurological disease.Ibuprofen for neuroprotection after cerebral ischemia.Prostaglandins, COX-2, and sensory perceptionTTF-1 action on the transcriptional regulation of cyclooxygenase-2 gene in the rat brain.Microsomal prostaglandin E synthase-1 contributes to ischaemic excitotoxicity through prostaglandin E2 EP3 receptors.COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration.The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged swordImaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic ratsRegional protein levels of cytosolic phospholipase A2 and cyclooxygenase-2 in Rhesus monkey brain as a function of ageMicrosomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury.Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappa B pathway and downstream enzymes involved in prostaglandin biosynthesis.Extended results of the Alzheimer's disease anti-inflammatory prevention trial.Differential effects of treadmill exercise on cyclooxygenase-2 in the rat hippocampus at early and chronic stages of diabetes.COX-2 inhibitors as adjunctive therapy in schizophrenia.Comparative study of analgesic efficacy and morphine-sparing effect of intramuscular dexketoprofen trometamol with ketoprofen or placebo after major orthopaedic surgery.Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.Regional Differences in the Neuronal Expression of Cyclooxygenase-2 (COX-2) in the Newborn Pig Brain.Fatty acid oxidation in the pathogenesis of Alzheimer's disease.Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.Bilateral common carotid artery ligation transiently changes brain lipid metabolism in rats.Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system.Prostaglandin E2 is an endogenous modulator of cerebellar development and complex behavior during a sensitive postnatal period.Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury.Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2.Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient miceSystemic LPS induces spinal inflammatory gene expression and impairs phrenic long-term facilitation following acute intermittent hypoxia.Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell LineTherapeutic targets in prostaglandin E2 signaling for neurologic disease.New tricks by an old dogma: mechanisms of the Organizational/Activational Hypothesis of steroid-mediated sexual differentiation of brain and behaviorTelmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activationModulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.
P2860
Q21129436-8B6C172F-C678-4E38-980A-40109D3D03D6Q21284455-41EB0B26-8153-41EA-8EEB-977DBB7E2D42Q24796541-963FD01E-A92A-494C-A69E-B2008439C0A3Q28195845-D217E2D2-2EBA-49B7-A91D-F3588379DD08Q28345876-6BD13D08-7E02-484B-A743-D79DE7BB65BFQ31010610-32CFBCB6-8502-4BAD-9AB3-5BF43F998896Q31900758-79909368-6053-403F-89F9-EF4D05D0A3C3Q33253297-EEDDBD38-660B-46FD-9325-F657F2BC9220Q33730643-5CAF44A2-0FD6-4EA8-ADA5-E157A4157C0AQ33756150-E2DDDF72-8CE1-474B-BA00-45E7D2BD9E4BQ33774158-264878B3-35C2-4AD1-B95A-3450C94878C9Q34081792-1070A8ED-2D39-4FAB-9F0B-D79FE5183623Q34103524-5AEB1C33-6EE0-4ACE-BD6E-43A88EDE346EQ34112849-CE216DDF-ECF2-4AB9-A0FC-AA7106B02AF7Q34119479-F1E8B12E-9E4F-4E8F-82E8-D0D2ECC4A931Q34157706-979F4385-F9F1-47AF-BB2F-A8C55B1182DAQ34351322-1B856B34-731E-41F0-B4C9-6314456CF6BAQ34655329-7F39EEFA-90B7-412C-B3C4-5CA9A61862A5Q34830891-8DD1A536-D050-40DC-A0B0-D7DB6B9D6B9FQ34947046-4B9AFBA3-572D-485B-A690-262AB402D1AFQ35146385-2209ACB4-E0E4-4B47-9697-802A33562E49Q35285469-0623F487-BC7E-416C-BB07-C7DA4F65CD5BQ35842551-B81FDF4A-2764-4E55-9BC9-5E7F6D0216B4Q35846685-7D19D9B7-7544-467B-8D91-CBF084A5151DQ35903755-207D7218-930A-46C7-AB57-1E0CBC146CEEQ36090929-038C97BD-F49A-43CB-AC19-22B9DC5FEC84Q36108432-0543EEE9-6E60-4175-93F2-BBF042803198Q36226179-EFD29F26-833F-4389-8F24-E74C919CB00DQ36338190-25B34E8A-6A5D-484F-A7D5-EAABE451F5F2Q36378519-66D89A41-B6FA-4EFF-B044-111E35A25F57Q36501969-782D1CC4-119C-4132-B9AA-55F936E8D2B7Q36662869-1F4AAE24-5765-4512-A0FB-1F6C5097D3A2Q36693623-A2863DDF-396E-4BE2-9218-66D4E8F490ADQ36711212-4D593834-5B19-4DA5-B163-50F2CADBFF5BQ36787427-3081253B-A9A0-4DF1-B6A5-55698CF77C67Q37057444-7157067B-6BEF-48E0-9AB9-9A16B51F4086Q37221356-BF3A8249-3C9A-4CFB-B19A-CA1E4C1F7518Q37343488-682D2C7E-6008-4244-8C88-A525A67C0D8CQ37631143-6C353088-6DB1-4D5C-99ED-86DA87570128Q37909028-9BFF29DC-D36E-40C6-9FC8-42FC0C285DAE
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Cyclooxygenases and the central nervous system.
@en
type
label
Cyclooxygenases and the central nervous system.
@en
prefLabel
Cyclooxygenases and the central nervous system.
@en
P2093
P1433
P1476
Cyclooxygenases and the central nervous system.
@en
P2093
Andreasson KI
Isakson PC
Kaufmann WE
P304
P356
10.1016/S0090-6980(97)00128-7
P577
1997-09-01T00:00:00Z